POXEL SA (Euronext - POXEL - FR0012432516), a clinical-stage biopharmaceutical company focused on the development of novel treatments for type 2 diabetes and metabolic disease, today announced that...
3655 promenade Sir William Osler, Montreal, QC, H3G 1Y6, CA/channelsCategory: Dept. of Biochemistry
Biochemistry Senior Seminar
Medicine and Health Sciences
3801 rue University, Montreal, QC, H3A 2B4, CA/channelsCategory: McGill University Health Centre (MUHC)
Research news
McGill Neurology Conference
Medicine and Health Sciences
MNI